Repaglinide Tablet
Product Images NDC 72603-810

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 72603-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

505 (Repaglinide Figure 1)

505 (Repaglinide Figure 1)
This text seems to display a comparison between different treatments or drugs related to Pioglitazone in terms of their impact on HbA1c levels over time. The graph shows a pattern of change in HbA1c (%) over treatment weeks. It appears to represent the effectiveness or differences between the mentioned treatments.*
FDA Label Image

Str (Repaglinide Str)

Str (Repaglinide Str)
FDA Label Image

333 (Repaglinide Tablets 0 5mg 100s)

333 (Repaglinide Tablets 0 5mg 100s)
Each tablet contains Repaglinide, USP 0.5 mg. The usual dosage can be found in the package. These tablets are manufactured for Northstar Rx LLC and the product is distributed as 100 tablets. It is recommended to store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). Bottles should be tightly closed, and the tablets should be kept out of reach of children. The tablets come in a tight container with child-resistant closure. For more information, it is advised to refer to the insert for full Prescribing Information.*
FDA Label Image

666 (Repaglinide Tablets 1mg 100s)

666 (Repaglinide Tablets 1mg 100s)
This text provides information about a medication called Repaglinide in tablet form, with each tablet containing 1 mg of the active ingredient. The recommended dosage can be found on the package. The tablets are to be stored at a temperature between 20°C to 25°C with some permitted excursions. It also includes details about the manufacturer, Northstar Rx LLC, and the total number of tablets in the container (100 tablets). Additional details indicate information about the NDC code, manufacturing information for the product, and expiry date. It is advised to protect the tablets from moisture, keep the bottles tightly closed, and out of reach of children. Dispensing should be done in a tight container with child-resistant closure.*
FDA Label Image

222 (Repaglinide Tablets 2mg 100s)

222 (Repaglinide Tablets 2mg 100s)
Each tablet contains Repaglinide, USP 2 mg. The standard dosage can be found on the package and the tablets are to be stored at 20° to 25°C (68° to 77°F). Protective measures include keeping the bottles tightly closed, protecting from moisture, and storing in a tight container with a child-resistant closure. The tablets are manufactured by Macleods Pharmaceuticals Ltd. Product of India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.